Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Hepatic radioembolization as a bridge to liver surgery.

Braat AJ, Huijbregts JE, Molenaar IQ, Borel Rinkes IH, van den Bosch MA, Lam MG.

Front Oncol. 2014 Jul 30;4:199. doi: 10.3389/fonc.2014.00199. eCollection 2014 Jul 30. Review.

2.

The role of 90Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic review.

Braat MN, Samim M, van den Bosch MA, Lam MG.

Clin Transl Imaging. 2016;4:283-295. Epub 2016 Apr 23. Review.

3.
4.

Endovascular radiofrequency ablation for varicose veins: an evidence-based analysis.

Health Quality Ontario..

Ont Health Technol Assess Ser. 2011;11(1):1-93. Epub 2011 Feb 1.

5.

Left ventricular assist devices: an evidence-based analysis.

Health Quality Ontario..

Ont Health Technol Assess Ser. 2004;4(3):1-69. Epub 2004 Mar 1.

6.

Is radiofrequency ablation applicable for recurrent hepatocellular carcinoma after liver transplantation?

Huang J, Yan L, Wu H, Yang J, Liao M, Zeng Y.

J Surg Res. 2016 Jan;200(1):122-30. doi: 10.1016/j.jss.2015.07.033. Epub 2015 Jul 28.

PMID:
26277218
7.

Use of yttrium-90 microsphere radioembolization of hepatocellular carcinoma as downstaging and bridge before liver transplantation: a case report.

Khalaf H, Alsuhaibani H, Al-Sugair A, Al-Mana H, Al-Mutawa A, Al-Kadhi Y, Al-Sebayel M.

Transplant Proc. 2010 Apr;42(3):994-8. doi: 10.1016/j.transproceed.2010.03.019.

PMID:
20430224
8.

Left-liver hypertrophy after therapeutic right-liver radioembolization is substantial but less than after portal vein embolization.

Garlipp B, de Baere T, Damm R, Irmscher R, van Buskirk M, Stübs P, Deschamps F, Meyer F, Seidensticker R, Mohnike K, Pech M, Amthauer H, Lippert H, Ricke J, Seidensticker M.

Hepatology. 2014 May;59(5):1864-73. doi: 10.1002/hep.26947. Epub 2014 Apr 1.

PMID:
24259442
9.

Percutaneous Image-guided Radiofrequency Ablation of Tumors in Inoperable Patients - Immediate Complications and Overall Safety.

Sahay A, Sahay N, Kapoor A, Kapoor J, Chatterjee A.

Indian J Palliat Care. 2016 Jan-Mar;22(1):67-73. doi: 10.4103/0973-1075.173951.

10.

Current concepts in transplant surgery: liver transplantation today.

Mehrabi A, Fonouni H, Müller SA, Schmidt J.

Langenbecks Arch Surg. 2008 May;393(3):245-60. doi: 10.1007/s00423-007-0262-6. Epub 2008 Feb 29. Review.

PMID:
18309513
11.

Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings.

Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, Fichtner-Feigl S, Lorf T, Goralcyk A, Hörbelt R, Kroemer A, Loss M, Rümmele P, Scherer MN, Padberg W, Königsrainer A, Lang H, Obed A, Schlitt HJ.

Ann Surg. 2012 Mar;255(3):405-14. doi: 10.1097/SLA.0b013e31824856f5.

PMID:
22330038
12.

Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma.

Weis S, Franke A, Mössner J, Jakobsen JC, Schoppmeyer K.

Cochrane Database Syst Rev. 2013 Dec 19;(12):CD003046. doi: 10.1002/14651858.CD003046.pub3. Review.

PMID:
24357457
13.

Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.

Seinstra BA, Defreyne L, Lambert B, Lam MG, Verkooijen HM, van Erpecum KJ, van Hoek B, van Erkel AR, Coenraad MJ, Al Younis I, van Vlierberghe H, van den Bosch MA.

Trials. 2012 Aug 23;13:144. doi: 10.1186/1745-6215-13-144.

14.

[Contralateral hepatic hypertrophy following unilateral yttrium-90 radioembolization : Implications for liver surgery].

Garlipp B, Seidensticker M, Jechorek D, Ptok H, Bruns CJ, Ricke J.

Chirurg. 2016 May;87(5):380-8. doi: 10.1007/s00104-016-0154-9. German.

PMID:
26879820
15.

Experience with more than 500 minimally invasive hepatic procedures.

Buell JF, Thomas MT, Rudich S, Marvin M, Nagubandi R, Ravindra KV, Brock G, McMasters KM.

Ann Surg. 2008 Sep;248(3):475-86. doi: 10.1097/SLA.0b013e318185e647.

PMID:
18791368
16.

The role of radiofrequency ablation in the treatment of primary and metastatic tumours of the liver: initial lessons learned.

Choy PY, Koea J, McCall J, Holden A, Osbourne M.

N Z Med J. 2002 Aug 9;115(1159):U128.

PMID:
12362172
17.

Long-term outcomes after hepatic resection combined with radiofrequency ablation for initially unresectable multiple and bilobar liver malignancies.

Qiu J, Chen S, Wu H.

J Surg Res. 2014 May 1;188(1):14-20. doi: 10.1016/j.jss.2013.11.1120. Epub 2013 Dec 8.

PMID:
24387841
18.

Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors.

Jiao LR, Hansen PD, Havlik R, Mitry RR, Pignatelli M, Habib N.

Am J Surg. 1999 Apr;177(4):303-6.

PMID:
10326848
19.

Hepatocellular carcinoma: interventional bridging to liver transplantation.

Lubienski A.

Transplantation. 2005 Sep 27;80(1 Suppl):S113-9. Review.

PMID:
16286887
20.

A single center experience of combined liver kidney transplantation.

Mehrabi A, Fonouni H, Ayoub E, Rahbari NN, Müller SA, Morath Ch, Seckinger J, Sadeghi M, Golriz M, Esmaeilzadeh M, Hillebrand N, Weitz J, Zeier M, Büchler MW, Schmidt J, Schmied BM.

Clin Transplant. 2009 Dec;23 Suppl 21:102-14. doi: 10.1111/j.1399-0012.2009.01146.x. Review.

PMID:
19930323

Supplemental Content

Support Center